Does antithrombotic therapy improve survival with colorectal cancer?
Abstract Background The study aimed to evaluate the prognosis for patients with colorectal cancer who underwent surgery while receiving antithrombotic therapy (ATT) across all disease stages and for patients at disease stages 0–III. Methods This retrospective cohort study included 710 Japanese patie...
Main Authors: | Kodai Takahashi, Hideto Ito, Masatoshi Hashimoto, Kazuhito Mita, Hideki Asakawa, Takashi Hayashi, Keiichi Fujino |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-08-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12957-017-1235-z |
Similar Items
-
Antithrombotic and anticoagulation therapies in cardiogenic shock: a critical review of the published literature
by: Razvan I. Radu, et al.
Published: (2021-12-01) -
Intelligent antithrombotic nanomedicines: Progress, opportunities, and challenges
by: Junchao Xu, et al.
Published: (2021-04-01) -
Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
by: Abdelmoniem Moustafa, et al.
Published: (2019-10-01) -
Antithrombotic Effects of Fostamatinib in Combination with Conventional Antiplatelet Drugs
by: Maan H. Harbi, et al.
Published: (2022-06-01) -
Post‐Intracranial Hemorrhage Antithrombotic Therapy in Patients With Atrial Fibrillation
by: Shin‐Yi Lin, et al.
Published: (2022-03-01)